EFFECT OF PUTIKADI LEPA AND SHVITRAHARA VARTI ALONG WITH SHASHILEKHA VATI IN VITILIGO.

A RANDOMISED CLINICAL TRIAL ON COMPARATIVE EFFICACY OF PUTIKADI LEPA AND SHVITRAHARA VARTI COADMINISTERED WITH SHASHILEKHA VATI IN VITILIGO PATIENTS AND ITS IMPACT ON ALPHA-MSH. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078679

Enrollment

Registered

2024-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with nonsegmental vitiligo with maximum 2 years of disease history. (2) Patients of age group: 21-45 years of either gender. (3) Patients willing to participate.

Exclusion criteria

Exclusion criteria: (1) Patients suffering from psychiatric illness. (2) Pregnant females and lactating women. (3) Patients suffering from any other Systemic Disorders like uncontrolled diabetes, hepatitis B positive, HIV positive, active case of tuberculosis, immunocompromised patient, kidney disease, other skin disease. (4) Cases of vitiligo due to burns. (5) Any allergic condition related to skin and hypersensitivity to any medicine.

Design outcomes

Primary

Measure	Time frame
improvement in shwitra assessed through VETF and VASI score in vitiligo patients.Timepoint: 0th day and 60th day.	—

Secondary

Measure	Time frame
change in level of Alpha-MSH at 0th to 60th day in blood samples of vitiligo patientsTimepoint: 0th day to 60th day	—

Countries

India

Contacts

Public ContactDr ANAND B MORE

ALL INDIA INSTITUTE OF AYURVEDA, NEW DELHI

vinay.bams99@gmail.com9560743062

Outcome results